GlassScriptPhysician profile
Charles Hamilton Dabbs
NPI 1992020598
$8,463.21
in general payments reported to CMS, 2019-2025
24 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,650 · 2020: $206 · 2021: $3,432 · 2022: $357 · 2023: $337 · 2024: $2,295 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $799 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $798.84 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,182.99 | 2021-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,170.25 | 2019 | |
| Novo Nordisk INC | $395.83 | 2020-2025 | Wegovy |
| Csl Behring | $364.91 | 2019-2024 | Kcentra |
| Abbvie INC. | $209.91 | 2021-2023 | Dalvance |
| Smith+Nephew, INC. | $156.55 | 2019-2023 | Renasys Go V2 Home |
| Ethicon US, LLC | $152.35 | 2022-2024 | Harmonic, Echelon; Endopath, Evarrest |
| Tela Bio, INC. | $129.84 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Organogenesis INC. | $124.99 | 2019 | |
| Allergan, INC. | $104.85 | 2019-2020 | |
| Integra Lifesciences Corporation | $66.16 | 2019-2025 | Integra, Surgimend, Omnigraft |
| Melinta Therapeutics, LLC | $53.49 | 2019 | |
| Shire North American Group INC | $52.30 | 2019 | |
| Kci USA, INC. | $51.33 | 2020-2023 | Prevena Restor Bellaform, V.A.C. Veraflo |
| Teleflex LLC | $44.58 | 2025 | Titan Sgs Bailout Chuck |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $35.91 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $30.12 | 2019-2020 | |
| Kls-Martin L.P. | $26.69 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $26.09 | 2025 | |
| Paratek Pharmaceuticals, INC. | $20.92 | 2020 | |
| Convatec INC. | $18.37 | 2021 | |
| Shionogi INC | $17.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.80 | 2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Dabbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.